Results 31 to 40 of about 614,277 (403)

Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy

Circulation: Heart Failure, 2020
Supplemental Digital Content is available in the text.
E. Ammirati, M. Frigerio, E. Adler, C. Basso, D. Birnie, M. Brambatti, M. Friedrich, K. Klingel, J. Lehtonen, J. Moslehi, P. Pedrotti, O. Rimoldi, H. Schultheiss, C. Tschöpe, L. Cooper, P. Camici   +15 more
semanticscholar   +1 more source

Availability and Utilization of Automated External Defibrillators in New York State Schools

Frontiers in Pediatrics, 2021
Background: Use of automated external defibrillators (AEDs) in out-of-hospital cardiac arrests (OHCAs) improve survival. Professional health organizations recommend that AEDs be available in crowded places, including schools but currently only 18 US ...
Milla Arabadjian, Milla Arabadjian, Stephanie Serrato, Mark V. Sherrid   +3 more
doaj   +1 more source

Contemporary characteristics and outcomes in chagasic heart failure compared with other nonischemic and ischemic cardiomyopathy [PDF]

, 2017
Background: Chagas’ disease is an important cause of cardiomyopathy in Latin America. We aimed to compare clinical characteristics and outcomes in patients with heart failure (HF) with reduced ejection fraction caused by Chagas’ disease, with other ...
Claudio R. Gimpelewicz, Efraín A. Gómez, Felipe Martinez, Felix Ramires, Jean L. Rouleau, John J.V. McMurray, Karl Swedberg, Kenneth Dickstein, Lars Køber, Li Shen, Luis Eduardo Echeverría, Luiz Carlos Bodanese, Michael R. Zile, Milton Packer, null null, Pardeep S. Jhund, Scott D. Solomon, William T. Abraham   +17 more
core   +3 more sources

CARDIOMYOPATHY: The diagnosis of hypertrophic cardiomyopathy [PDF]

Heart, 2001
Although the pathology of hypertrophic cardiomyopathy (HCM) was first described by French pathologists in the mid 19th century, it remained for the virtually simultaneous reports of Brock and Teare in England some 43 years ago to bring modern attention to this fascinating entity.1 2 Subsequent to these surgical1 and pathological2 observations, there ...
openaire   +3 more sources

Special topic: The association between pulse ingredients and canine dilated cardiomyopathy: addressing the knowledge gaps before establishing causation. [PDF]

, 2019
In July 2018, the Food and Drug Administration warned about a possible relationship between dilated cardiomyopathy (DCM) in dogs and the consumption of dog food formulated with potatoes and pulse ingredients.
Adin, Alroy, Anna K Shoveller, Arslan, Avilés-Gaxiola, Backus, Baker, Baker, Bakker, Borgarelli, Butterwick, Bélanger, Cattanach, Christopher P F Marinangeli, Columbus, Daniel A Columbus, de Godoy, Degen, Dodd, Dutton, Fascetti, Flanagan, Freeman, Freeman, Freeman, Gloaguen, Greg Aldrich, Haber, Homann, Hoppel, Hou, Hurrell, Huxtable, Ito, Jennifer A Larsen, Johnson, Johnson, Kaplan, Kari J Ekenstedt, Keene, Kim, Kim, Kittleson, Ko, Kramer, Lien, Linder, Lynn Weber, Mansilla, Marinangeli, Maron, Marshall, Martin, Mathai, Menniti, Merheb, Meurs, Meurs, Moehn, Moise, Monnet, Nardelli, Nyachoti, Owczarek-Lipska, O’Máille, Patterson, Pion, Pion, Rice, Roberfroid, Robinson, Robinson, Răşanu, Sanderson, Sarah K Abood, Schaffer, Sisson, Spitze, Stoll, Story, Swanson, Teodorowicz, Tosh, Tôrres, Werner, Wilfredo D Mansilla, Worden, Yamka, Žilić   +88 more
core   +1 more source

CARDIOMYOPATHY: The cardiomyopathies: an overview [PDF]

Heart, 2000
The recent revision (table 1) of the definition of a cardiomyopathy by the World Health Organization1 recognises that ventricular dysfunction can result from a failure to correct volume or pressure overload in valve disease or to control hypertension. Loss of myocardium caused by coronary artery disease also leads to severe ventricular dysfunction. All
openaire   +2 more sources

Differences in molecular phenotype in mouse and human hypertrophic cardiomyopathy

Scientific Reports, 2021
Hypertrophic cardiomyopathy (HCM) is characterized by phenotypic heterogeneity. We investigated the molecular basis of the cardiac phenotype in two mouse models at established disease stage (mouse-HCM), and human myectomy tissue (human-HCM).
Styliani Vakrou, Yamin Liu, Li Zhu, Gabriela V. Greenland, Bahadir Simsek, Virginia B. Hebl, Yufan Guan, Kirubel Woldemichael, Conover C. Talbot, Miguel A. Aon, Ryuya Fukunaga, M. Roselle Abraham   +11 more
doaj   +1 more source

Investigating the role of uncoupling of troponin I phosphorylation from changes in myofibrillar Ca(2+)-sensitivity in the pathogenesis of cardiomyopathy. [PDF]

, 2014
Contraction in the mammalian heart is controlled by the intracellular Ca2+ concentration as it is in all striated muscle, but the heart has an additional signalling system that comes into play to increase heart rate and cardiac output during exercise or ...
Marston, SB, Messer, AE
core   +2 more sources

Peripartum Cardiomyopathy

Journal of Education and Teaching in Emergency Medicine, 2023
This simulation is appropriate for emergency medicine (EM) residents of all levels.Peripartum cardiomyopathy (PPCM) is a rare, idiopathic condition that occurs in the mother around the time of childbirth. Heart failure with reduced ejection fraction and/or reduced systolic function diagnosed in patients during the last month of pregnancy or up to five ...
Morris, Victoria L, Mendoza, Carolina, Stevens, Gowri S, Wilson, Jessica L, Kosoko, Adeola A   +4 more
openaire   +4 more sources

Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016
BackgroundThe subcutaneous implantable cardioverter defibrillator (S‐ICD) has been developed to avert risks associated with transvenous defibrillator leads. The technology is attractive for younger patients, such as those with hypertrophic cardiomyopathy
Jonathan Weinstock, Yousef H. Bader, Martin S. Maron, Ethan J. Rowin, Mark S. Link   +4 more
doaj   +1 more source